The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Irish Pharmaceutical Healthcare Association naming Dara Calleary .

Filed returns
14
match these filters
Matching filed returns per period 0 0 1 1 2 Sep–Dec 2015: 1 filed returns Jan–Apr 2017: 1 filed returns Sep–Dec 2017: 1 filed returns Jan–Apr 2018: 1 filed returns May–Aug 2018: 1 filed returns Sep–Dec 2018: 2 filed returns Jan–Apr 2019: 2 filed returns Sep–Dec 2019: 1 filed returns Jan–Apr 2020: 2 filed returns May–Aug 2020: 1 filed returns Sep–Dec 2022: 1 filed returns 2017 2018 2019 2020
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
Sep–Dec 2022 Irish Pharmaceutical Healthcare Association Health Forum, 'The Future of Medicines' (Public policy or programme) 1 On lobbying.ie
May–Aug 2020 Irish Pharmaceutical Healthcare Association Health Interaction between DPER and DoH/HSE on funding for new medicines (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2020 Irish Pharmaceutical Healthcare Association Health Importance of a definitive and focused medicines policy, especially regarding access, in the Programme for Government (Public policy or programme) 12 On lobbying.ie
Jan–Apr 2020 Irish Pharmaceutical Healthcare Association Health Importance of medicines policy in General Election dialogue (Public policy or programme) 2 On lobbying.ie
Sep–Dec 2019 Irish Pharmaceutical Healthcare Association Health Report commissioned by Department of Health from Mazars on drug reimbursement system (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2019 Irish Pharmaceutical Healthcare Association Health IPHA policy document "Manifesto for Better Health" (Public policy or programme) 14 On lobbying.ie
Jan–Apr 2019 Irish Pharmaceutical Healthcare Association Health Originator pharmaceutical industry's preparations for Brexit (Public policy or programme) 9 On lobbying.ie
Sep–Dec 2018 Irish Pharmaceutical Healthcare Association Health Inclusion of IPHA position on access to innovative medicines in discussions on renewal of Confidence and Supply Agreement (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2018 Irish Pharmaceutical Healthcare Association Health Liaison with Deputy Dara Calleary regarding the reimbursement status of Spinraza (Public policy or programme) 1 On lobbying.ie
May–Aug 2018 Irish Pharmaceutical Healthcare Association Health Briefing of Fianna Fáil Deputy Leader and Director of Policy, Dara Calleary, TD (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2018 Irish Pharmaceutical Healthcare Association Health To arrange meetings with senior Fianna Fáil front benchers, including Party Leader Micheál Martin TD (Public policy or programme) 3 On lobbying.ie
Sep–Dec 2017 Irish Pharmaceutical Healthcare Association Health To provide briefings for members of the Oireachtas on reimbursement issues (Public policy or programme) 2 On lobbying.ie
Jan–Apr 2017 Irish Pharmaceutical Healthcare Association Health The operation of the Framework Agreement and policy issues such as pricing, reimbursement, early access schemes and transparency (Public policy or programme) 13 On lobbying.ie
Sep–Dec 2015 Irish Pharmaceutical Healthcare Association Health IPHA policy priorities as set out in "Policy and Budgetary Perspectives 2015 - 2016" document (Public policy or programme) 21 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 14 100.0%